Cysvax

Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.

Indian Immunologicals limited also has a state of the art facility located in Genome Valley for oral solid dosage forms and injectable (small volume parenteral). With sufficient plant capacities, we can offer contract manufacturing services for the same.

The brochure gives detailed information about the Human health vaccines that are offered by IIL for export purpose. 

The brochure gives an overview about the Animal health product portfolio of IIL. It primarily includes vaccines as well as formulations.

IIL Corporate Brochure

List of IIL's Animal Health Vaccines and Formulations

List of IIL's Human Health Products

Brochure outlining IIL's technical capabilities.

An interview with Dr K Anand Kumar, Managing director, Indian Immunologicals Limited regarding the company's future growth plans & current R&D pipeline.